BIOSPECIFICS TECHNOLOGIES CORP Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2003-06: Study NCT00260429; Company role Collaborator; Phase Phase 3; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2003-06 | NCT00260429 Collagenase in the Treatment of Dupuytrens Disease | Collaborator Lead: Stony Brook University | Phase 3 | Completed Results posted | Dupuytren's Disease | 38 | 2008-04 |